Iridex (IRIX) Cash & Current Investments (2010 - 2026)
Iridex's (IRIX) quarterly Cash & Current Investments came in at $4.6 million in Q2 2026, down 36.57% year-on-year from $7.2 million in Q2 2025, and down 23.77% quarter-over-quarter from $6.0 million in Q1 2026.
Iridex (IRIX) Cash & Current Investments (2010 - 2026) Analysis & Trends
Iridex's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $4.6 million for Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 36.57% year-over-year to $4.6 million in Q2 2026; TTM through Apr 2026 was $4.6 million, a 36.57% decrease from a year earlier, with the FY2026 full-year figure at $6.0 million, up 152.53% from the prior year.
- Cash & Current Investments slipped to $4.6 million in Q2 2026 per IRIX's latest filing, from $6.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $23.9 million in Q1 2022 and bottomed at $2.4 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $7.1 million (2023), against an average of $9.7 million.
- Across the five-year window, Cash & Current Investments slumped 66.06% in 2024 and jumped 152.53% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $13.9 million in 2022, then slumped by 49.48% to $7.0 million in 2023, then slumped by 66.06% to $2.4 million in 2024, then surged by 133.47% to $5.6 million in 2025, then declined by 17.55% to $4.6 million in 2026.
- Per Business Quant, the three latest IRIX Cash & Current Investments figures stand at $4.6 million (Q2 2026), $6.0 million (Q1 2026), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Iridex | 15.39 Mn | 10.79 Mn | 4.74 Mn | 4.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 4.60 Mn |
| Jan 3, 2026 | 6.03 Mn |
| Sep 27, 2025 | 5.57 Mn |
| Jun 28, 2025 | 6.78 Mn |
| Mar 29, 2025 | 7.24 Mn |
| Dec 28, 2024 | 2.39 Mn |
| Sep 28, 2024 | 3.86 Mn |
| Jun 29, 2024 | 4.11 Mn |
| Mar 30, 2024 | 5.42 Mn |
| Dec 30, 2023 | 7.03 Mn |
| Sep 30, 2023 | 7.98 Mn |
| Jul 1, 2023 | 9.82 Mn |
| Apr 1, 2023 | 11.05 Mn |
| Dec 31, 2022 | 13.92 Mn |
| Oct 1, 2022 | 15.86 Mn |
| Jul 2, 2022 | 17.97 Mn |
| Apr 2, 2022 | 20.62 Mn |
| Jan 1, 2022 | 23.85 Mn |
| Oct 2, 2021 | 25.57 Mn |
| Jul 3, 2021 | 26.26 Mn |